Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-0074 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
filingDate |
1986-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1d6cc46a1571f609b66a860acda47ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0edab85753eaa45cfb4132a540518e1a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4dc76857c4f45bdcbb4a5962ba7e992 |
publicationDate |
1986-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0196271-A2 |
titleOfInvention |
Estradiol and/or estriol glycolic-acid esters |
abstract |
Glycoester of estradiol (E 2 ) and estriol (E 3 ) of the general formula I. whereinn n n Z represents a hydroxy group or the group -O-CO-R with R in the meaning of a methyl or phenyl group.n n n With the new esters, an even and persistent level of estrogen can be achieved in the form of an aqueous crystal suspension. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8614232-B2 |
priorityDate |
1985-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |